Abstract
A major obstacle for joint drug delivery is to penetrate the dense, negatively charged cartilage matrix.
Previous studies have extensively investigated particle approaches to increase uptake efficiency into
tissues but have neglected to address potential interactions with the synovial fluid. Here, we developed
a nanoparticle (NP) panel with varying PEGylation and incubated them with synovial fluid from either
osteoarthritic (OA) or rheumatoid arthritis (RA) patients, or fetal calf serum (FCS). Compared to nonprotein-
covered NPs, the formed protein coronas majorly impacted NP uptake into cartilage tissue and
dictated their uptake in chondrocytes and monocytes - a measure of targeting efficiency and clearance
potential. Utilizing a quantitative proteomics approach, we identified certain families of proteins on all
panel members irrespective of the NP modifications. Nonetheless, NP-, and protein-specific differences
were also observed between the groups, and candidate proteins were identified that could account for
the observed differences. This study is the first to demonstrate how protein coronas from different
biological origins impact NP uptake into cartilage, emphasizing the importance of considering the
several aspects of the biological microenvironment for successful translation of drug delivery vehicles
into clinics.
Supplementary materials
Title
Supporting Information
Description
Supporting information on NMR analysis and toxicity studies
Actions